For perimenopause and menopause Up to 85% of women experience menopause-related symptoms, including weight redistribution, fatigue, mood changes, and joint pain
Switching to GLP-1 Booster was the best choice - Ive kept the weight off, feel good, and saved a ton
About one-third of participants lost 20 percent or more. LaValle explains that the 16.6 percent average weight loss seen with the Wegovy pill reflects several factors, including the higher 25 mg dose, the 64-week length of the trial, the diet and activity coaching participants received and the strong biological effects of semaglutide as a GLP-1
Then there are the side effects
Jrnvall H, Carlquist M, Kwauk S, et al
We look forward to working with you